Detalhe da pesquisa
1.
Development of a First-in-Class Unimolecular Dual GIP/GLP-2 Analogue, GL-0001, for the Treatment of Bone Fragility.
J Bone Miner Res
; 38(5): 733-748, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36850034
2.
Synchronous development and recurrence of multiple myeloma and clear cell renal cell carcinoma: Report of two cases.
Joint Bone Spine
; 87(4): 351-353, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32147564
3.
Enteroendocrine K Cells Exert Complementary Effects to Control Bone Quality and Mass in Mice.
J Bone Miner Res
; 35(7): 1363-1374, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32155286
4.
Incretin-based therapy for the treatment of bone fragility in diabetes mellitus.
Peptides
; 100: 108-113, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29412811
5.
Efficacy of targeting bone-specific GIP receptor in ovariectomy-induced bone loss.
J Endocrinol
; 2018 Aug 18.
Artigo
Inglês
| MEDLINE | ID: mdl-30121578